Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik
India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers
The data suggest that a booster dose given within 6 to 12 months after the second dose may help maintain a high level of protection against COVID-19.
This multi-centre study (sites in the US and Europe) comprising about 387 patients is likely to be completed in about 36 months and the topline result is expected by the end of 2024
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
The approval allows it to market its products in the country
Investment of Rs 235 crores to add 411 beds in the next 18 months
The company reports revenue growth of 26% and PAT growth of 21% YoY
The hospital chain aggressively embarks on digitisation and is e-health ready
The MoU was signed on World Organ Donation Day which falls on August 13
Subscribe To Our Newsletter & Stay Updated
